Stada Group
Dr. Can Sümer is a seasoned professional in quality assurance and commercial quality management, currently serving as the Senior Global Commercial Quality Assurance Manager at STADA Group since November 2020. With extensive experience in both regulatory compliance and quality oversight, Dr. Sümer previously held roles as Senior Manager of Quality Assurance and Qualified Person at Amgen, and Quality Assurance Manager at Novartis, where responsibilities included GxP compliance and management of audits and inspections. Dr. Sümer's career began with roles in clinical research at Merck Sharp & Dohme and Quintiles. Dr. Sümer holds a Doctor of Medicine (M.D.) from Istanbul University and completed a residency in Family Medicine at Istanbul Kartal Education and Research Hospital, focusing on research related to preterm birth.
This person is not in the org chart
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.